カテゴリー： Market Monitor Global, 世界, 医療/バイオ

成人用ワクチンのグローバル市場展望 2023年-2029年：一価ワクチン、多価ワクチン

◆英語タイトル：Adult Vaccines Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12536）◆商品コード：MMG23DC12536
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：125
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の成人用ワクチン市場規模と予測を収録しています。・世界の成人用ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の成人用ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の成人用ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一価ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

成人用ワクチンのグローバル主要企業は、Solvay Pharmaceuticals、 Moderna、 BioCSL (Seqirus)、 Aventis Pasteur、 Sanofi Pasteur、 Pfizer Inc.、 Merck & Co. Inc.、 GlaxoSmithKline Plc、 Novartis AG、 Johnson & Johnson、 BioNTech、 Bharat Biotech International Limited、 Zhifei、 Wyeth Vaccines、 AstraZeneca Plc、 Medimmune、 Sinovac、 Baxter International Healthcare Company、 Chiron Vaccines、 Serum Institute of India.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、成人用ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の成人用ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の成人用ワクチン市場：タイプ別市場シェア、2022年
・一価ワクチン、多価ワクチン

世界の成人用ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の成人用ワクチン市場：用途別市場シェア、2022年
・民間病院、政府病院

世界の成人用ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の成人用ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における成人用ワクチンのグローバル売上、2018年-2023年
・主要企業における成人用ワクチンのグローバル売上シェア、2022年
・主要企業における成人用ワクチンのグローバル販売量、2018年-2023年
・主要企業における成人用ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Solvay Pharmaceuticals、 Moderna、 BioCSL (Seqirus)、 Aventis Pasteur、 Sanofi Pasteur、 Pfizer Inc.、 Merck & Co. Inc.、 GlaxoSmithKline Plc、 Novartis AG、 Johnson & Johnson、 BioNTech、 Bharat Biotech International Limited、 Zhifei、 Wyeth Vaccines、 AstraZeneca Plc、 Medimmune、 Sinovac、 Baxter International Healthcare Company、 Chiron Vaccines、 Serum Institute of India.

*************************************************************

・調査・分析レポートの概要
成人用ワクチン市場の定義
市場セグメント
世界の成人用ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の成人用ワクチン市場規模
世界の成人用ワクチン市場規模：2022年 VS 2029年
世界の成人用ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの成人用ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の成人用ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：一価ワクチン、多価ワクチン
成人用ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：民間病院、政府病院
成人用ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別成人用ワクチン市場規模 2022年と2029年
地域別成人用ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Solvay Pharmaceuticals、 Moderna、 BioCSL (Seqirus)、 Aventis Pasteur、 Sanofi Pasteur、 Pfizer Inc.、 Merck & Co. Inc.、 GlaxoSmithKline Plc、 Novartis AG、 Johnson & Johnson、 BioNTech、 Bharat Biotech International Limited、 Zhifei、 Wyeth Vaccines、 AstraZeneca Plc、 Medimmune、 Sinovac、 Baxter International Healthcare Company、 Chiron Vaccines、 Serum Institute of India.
...

This research report provides a comprehensive analysis of the Adult Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Adult Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Adult Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Adult Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Adult Vaccines market presents opportunities for various stakeholders, including Private Healthcare Firms, Government Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Adult Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Adult Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Adult Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Adult Vaccines market.
Market Overview: The report provides a comprehensive overview of the Adult Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monovalent Vaccines, Multivalent Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Adult Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Adult Vaccines market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Adult Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Adult Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Adult Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Adult Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Adult Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Adult Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Adult Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monovalent Vaccines
Multivalent Vaccines
Market segment by Application
Private Healthcare Firms
Government Hospitals
Global Adult Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Solvay Pharmaceuticals
Moderna
BioCSL (Seqirus)
Aventis Pasteur
Sanofi Pasteur
Pfizer Inc.
Merck & Co. Inc.
GlaxoSmithKline Plc
Novartis AG
Johnson & Johnson
BioNTech
Bharat Biotech International Limited
Zhifei
Wyeth Vaccines
AstraZeneca Plc
Medimmune
Sinovac
Baxter International Healthcare Company
Chiron Vaccines
Serum Institute of India.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adult Vaccines, market overview.
Chapter 2: Global Adult Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Adult Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adult Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adult Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Adult Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult Vaccines Overall Market Size
2.1 Global Adult Vaccines Market Size: 2022 VS 2029
2.2 Global Adult Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Adult Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Adult Vaccines Players in Global Market
3.2 Top Global Adult Vaccines Companies Ranked by Revenue
3.3 Global Adult Vaccines Revenue by Companies
3.4 Global Adult Vaccines Sales by Companies
3.5 Global Adult Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Adult Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Adult Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adult Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Adult Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Adult Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Adult Vaccines Market Size Markets, 2022 & 2029
4.1.2 Monovalent Vaccines
4.1.3 Multivalent Vaccines
4.2 By Type – Global Adult Vaccines Revenue & Forecasts
4.2.1 By Type – Global Adult Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Adult Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Adult Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Adult Vaccines Sales & Forecasts
4.3.1 By Type – Global Adult Vaccines Sales, 2018-2023
4.3.2 By Type – Global Adult Vaccines Sales, 2024-2029
4.3.3 By Type – Global Adult Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Adult Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adult Vaccines Market Size, 2022 & 2029
5.1.2 Private Healthcare Firms
5.1.3 Government Hospitals
5.2 By Application – Global Adult Vaccines Revenue & Forecasts
5.2.1 By Application – Global Adult Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Adult Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Adult Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Adult Vaccines Sales & Forecasts
5.3.1 By Application – Global Adult Vaccines Sales, 2018-2023
5.3.2 By Application – Global Adult Vaccines Sales, 2024-2029
5.3.3 By Application – Global Adult Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Adult Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Adult Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Adult Vaccines Revenue & Forecasts
6.2.1 By Region – Global Adult Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Adult Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Adult Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Adult Vaccines Sales & Forecasts
6.3.1 By Region – Global Adult Vaccines Sales, 2018-2023
6.3.2 By Region – Global Adult Vaccines Sales, 2024-2029
6.3.3 By Region – Global Adult Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Adult Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Adult Vaccines Sales, 2018-2029
6.4.3 US Adult Vaccines Market Size, 2018-2029
6.4.4 Canada Adult Vaccines Market Size, 2018-2029
6.4.5 Mexico Adult Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Adult Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Adult Vaccines Sales, 2018-2029
6.5.3 Germany Adult Vaccines Market Size, 2018-2029
6.5.4 France Adult Vaccines Market Size, 2018-2029
6.5.5 U.K. Adult Vaccines Market Size, 2018-2029
6.5.6 Italy Adult Vaccines Market Size, 2018-2029
6.5.7 Russia Adult Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Adult Vaccines Market Size, 2018-2029
6.5.9 Benelux Adult Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Adult Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Adult Vaccines Sales, 2018-2029
6.6.3 China Adult Vaccines Market Size, 2018-2029
6.6.4 Japan Adult Vaccines Market Size, 2018-2029
6.6.5 South Korea Adult Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Adult Vaccines Market Size, 2018-2029
6.6.7 India Adult Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Adult Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Adult Vaccines Sales, 2018-2029
6.7.3 Brazil Adult Vaccines Market Size, 2018-2029
6.7.4 Argentina Adult Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Adult Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Adult Vaccines Sales, 2018-2029
6.8.3 Turkey Adult Vaccines Market Size, 2018-2029
6.8.4 Israel Adult Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Adult Vaccines Market Size, 2018-2029
6.8.6 UAE Adult Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Solvay Pharmaceuticals
7.1.1 Solvay Pharmaceuticals Company Summary
7.1.2 Solvay Pharmaceuticals Business Overview
7.1.3 Solvay Pharmaceuticals Adult Vaccines Major Product Offerings
7.1.4 Solvay Pharmaceuticals Adult Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Solvay Pharmaceuticals Key News & Latest Developments
7.2 Moderna
7.2.1 Moderna Company Summary
7.2.2 Moderna Business Overview
7.2.3 Moderna Adult Vaccines Major Product Offerings
7.2.4 Moderna Adult Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Moderna Key News & Latest Developments
7.3 BioCSL (Seqirus)
7.3.1 BioCSL (Seqirus) Company Summary
7.3.2 BioCSL (Seqirus) Business Overview
7.3.3 BioCSL (Seqirus) Adult Vaccines Major Product Offerings
7.3.4 BioCSL (Seqirus) Adult Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 BioCSL (Seqirus) Key News & Latest Developments
7.4 Aventis Pasteur
7.4.1 Aventis Pasteur Company Summary
7.4.2 Aventis Pasteur Business Overview
7.4.3 Aventis Pasteur Adult Vaccines Major Product Offerings
7.4.4 Aventis Pasteur Adult Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Aventis Pasteur Key News & Latest Developments
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Company Summary
7.5.2 Sanofi Pasteur Business Overview
7.5.3 Sanofi Pasteur Adult Vaccines Major Product Offerings
7.5.4 Sanofi Pasteur Adult Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Pasteur Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Adult Vaccines Major Product Offerings
7.6.4 Pfizer Inc. Adult Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 Merck & Co. Inc.
7.7.1 Merck & Co. Inc. Company Summary
7.7.2 Merck & Co. Inc. Business Overview
7.7.3 Merck & Co. Inc. Adult Vaccines Major Product Offerings
7.7.4 Merck & Co. Inc. Adult Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Merck & Co. Inc. Key News & Latest Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Company Summary
7.8.2 GlaxoSmithKline Plc Business Overview
7.8.3 GlaxoSmithKline Plc Adult Vaccines Major Product Offerings
7.8.4 GlaxoSmithKline Plc Adult Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Plc Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Adult Vaccines Major Product Offerings
7.9.4 Novartis AG Adult Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Adult Vaccines Major Product Offerings
7.10.4 Johnson & Johnson Adult Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 BioNTech
7.11.1 BioNTech Company Summary
7.11.2 BioNTech Business Overview
7.11.3 BioNTech Adult Vaccines Major Product Offerings
7.11.4 BioNTech Adult Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 BioNTech Key News & Latest Developments
7.12 Bharat Biotech International Limited
7.12.1 Bharat Biotech International Limited Company Summary
7.12.2 Bharat Biotech International Limited Business Overview
7.12.3 Bharat Biotech International Limited Adult Vaccines Major Product Offerings
7.12.4 Bharat Biotech International Limited Adult Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Bharat Biotech International Limited Key News & Latest Developments
7.13 Zhifei
7.13.1 Zhifei Company Summary
7.13.2 Zhifei Business Overview
7.13.3 Zhifei Adult Vaccines Major Product Offerings
7.13.4 Zhifei Adult Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Zhifei Key News & Latest Developments
7.14 Wyeth Vaccines
7.14.1 Wyeth Vaccines Company Summary
7.14.2 Wyeth Vaccines Business Overview
7.14.3 Wyeth Vaccines Adult Vaccines Major Product Offerings
7.14.4 Wyeth Vaccines Adult Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Wyeth Vaccines Key News & Latest Developments
7.15 AstraZeneca Plc
7.15.1 AstraZeneca Plc Company Summary
7.15.2 AstraZeneca Plc Business Overview
7.15.3 AstraZeneca Plc Adult Vaccines Major Product Offerings
7.15.4 AstraZeneca Plc Adult Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 AstraZeneca Plc Key News & Latest Developments
7.16 Medimmune
7.16.1 Medimmune Company Summary
7.16.2 Medimmune Business Overview
7.16.3 Medimmune Adult Vaccines Major Product Offerings
7.16.4 Medimmune Adult Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Medimmune Key News & Latest Developments
7.17 Sinovac
7.17.1 Sinovac Company Summary
7.17.2 Sinovac Business Overview
7.17.3 Sinovac Adult Vaccines Major Product Offerings
7.17.4 Sinovac Adult Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Sinovac Key News & Latest Developments
7.18 Baxter International Healthcare Company
7.18.1 Baxter International Healthcare Company Company Summary
7.18.2 Baxter International Healthcare Company Business Overview
7.18.3 Baxter International Healthcare Company Adult Vaccines Major Product Offerings
7.18.4 Baxter International Healthcare Company Adult Vaccines Sales and Revenue in Global (2018-2023)
7.18.5 Baxter International Healthcare Company Key News & Latest Developments
7.19 Chiron Vaccines
7.19.1 Chiron Vaccines Company Summary
7.19.2 Chiron Vaccines Business Overview
7.19.3 Chiron Vaccines Adult Vaccines Major Product Offerings
7.19.4 Chiron Vaccines Adult Vaccines Sales and Revenue in Global (2018-2023)
7.19.5 Chiron Vaccines Key News & Latest Developments
7.20 Serum Institute of India.
7.20.1 Serum Institute of India. Company Summary
7.20.2 Serum Institute of India. Business Overview
7.20.3 Serum Institute of India. Adult Vaccines Major Product Offerings
7.20.4 Serum Institute of India. Adult Vaccines Sales and Revenue in Global (2018-2023)
7.20.5 Serum Institute of India. Key News & Latest Developments
8 Global Adult Vaccines Production Capacity, Analysis
8.1 Global Adult Vaccines Production Capacity, 2018-2029
8.2 Adult Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Adult Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adult Vaccines Supply Chain Analysis
10.1 Adult Vaccines Industry Value Chain
10.2 Adult Vaccines Upstream Market
10.3 Adult Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adult Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Adult Vaccines in Global Market
Table 2. Top Adult Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Adult Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Adult Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Adult Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Adult Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Adult Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Adult Vaccines Product Type
Table 9. List of Global Tier 1 Adult Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adult Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Adult Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Adult Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Adult Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Adult Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Adult Vaccines Sales (K Units), 2024-2029
Table 16. By Application – Global Adult Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Adult Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Adult Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Adult Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Adult Vaccines Sales (K Units), 2024-2029
Table 21. By Region – Global Adult Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Adult Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Adult Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Adult Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Adult Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Adult Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Adult Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Adult Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Adult Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Adult Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Adult Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Adult Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Adult Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Adult Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Adult Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Adult Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Adult Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Adult Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Adult Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Adult Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Adult Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Adult Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Adult Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Adult Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Adult Vaccines Sales, (K Units), 2024-2029
Table 46. Solvay Pharmaceuticals Company Summary
Table 47. Solvay Pharmaceuticals Adult Vaccines Product Offerings
Table 48. Solvay Pharmaceuticals Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Solvay Pharmaceuticals Key News & Latest Developments
Table 50. Moderna Company Summary
Table 51. Moderna Adult Vaccines Product Offerings
Table 52. Moderna Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Moderna Key News & Latest Developments
Table 54. BioCSL (Seqirus) Company Summary
Table 55. BioCSL (Seqirus) Adult Vaccines Product Offerings
Table 56. BioCSL (Seqirus) Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. BioCSL (Seqirus) Key News & Latest Developments
Table 58. Aventis Pasteur Company Summary
Table 59. Aventis Pasteur Adult Vaccines Product Offerings
Table 60. Aventis Pasteur Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Aventis Pasteur Key News & Latest Developments
Table 62. Sanofi Pasteur Company Summary
Table 63. Sanofi Pasteur Adult Vaccines Product Offerings
Table 64. Sanofi Pasteur Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sanofi Pasteur Key News & Latest Developments
Table 66. Pfizer Inc. Company Summary
Table 67. Pfizer Inc. Adult Vaccines Product Offerings
Table 68. Pfizer Inc. Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Inc. Key News & Latest Developments
Table 70. Merck & Co. Inc. Company Summary
Table 71. Merck & Co. Inc. Adult Vaccines Product Offerings
Table 72. Merck & Co. Inc. Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Merck & Co. Inc. Key News & Latest Developments
Table 74. GlaxoSmithKline Plc Company Summary
Table 75. GlaxoSmithKline Plc Adult Vaccines Product Offerings
Table 76. GlaxoSmithKline Plc Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. GlaxoSmithKline Plc Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Adult Vaccines Product Offerings
Table 80. Novartis AG Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Adult Vaccines Product Offerings
Table 84. Johnson & Johnson Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. BioNTech Company Summary
Table 87. BioNTech Adult Vaccines Product Offerings
Table 88. BioNTech Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. BioNTech Key News & Latest Developments
Table 90. Bharat Biotech International Limited Company Summary
Table 91. Bharat Biotech International Limited Adult Vaccines Product Offerings
Table 92. Bharat Biotech International Limited Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Bharat Biotech International Limited Key News & Latest Developments
Table 94. Zhifei Company Summary
Table 95. Zhifei Adult Vaccines Product Offerings
Table 96. Zhifei Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Zhifei Key News & Latest Developments
Table 98. Wyeth Vaccines Company Summary
Table 99. Wyeth Vaccines Adult Vaccines Product Offerings
Table 100. Wyeth Vaccines Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Wyeth Vaccines Key News & Latest Developments
Table 102. AstraZeneca Plc Company Summary
Table 103. AstraZeneca Plc Adult Vaccines Product Offerings
Table 104. AstraZeneca Plc Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. AstraZeneca Plc Key News & Latest Developments
Table 106. Medimmune Company Summary
Table 107. Medimmune Adult Vaccines Product Offerings
Table 108. Medimmune Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Medimmune Key News & Latest Developments
Table 110. Sinovac Company Summary
Table 111. Sinovac Adult Vaccines Product Offerings
Table 112. Sinovac Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Sinovac Key News & Latest Developments
Table 114. Baxter International Healthcare Company Company Summary
Table 115. Baxter International Healthcare Company Adult Vaccines Product Offerings
Table 116. Baxter International Healthcare Company Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Baxter International Healthcare Company Key News & Latest Developments
Table 118. Chiron Vaccines Company Summary
Table 119. Chiron Vaccines Adult Vaccines Product Offerings
Table 120. Chiron Vaccines Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Chiron Vaccines Key News & Latest Developments
Table 122. Serum Institute of India. Company Summary
Table 123. Serum Institute of India. Adult Vaccines Product Offerings
Table 124. Serum Institute of India. Adult Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Serum Institute of India. Key News & Latest Developments
Table 126. Adult Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Adult Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Adult Vaccines Production by Region, 2018-2023 (K Units)
Table 129. Global Adult Vaccines Production by Region, 2024-2029 (K Units)
Table 130. Adult Vaccines Market Opportunities & Trends in Global Market
Table 131. Adult Vaccines Market Drivers in Global Market
Table 132. Adult Vaccines Market Restraints in Global Market
Table 133. Adult Vaccines Raw Materials
Table 134. Adult Vaccines Raw Materials Suppliers in Global Market
Table 135. Typical Adult Vaccines Downstream
Table 136. Adult Vaccines Downstream Clients in Global Market
Table 137. Adult Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Adult Vaccines Segment by Type in 2022
Figure 2. Adult Vaccines Segment by Application in 2022
Figure 3. Global Adult Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adult Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Adult Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Adult Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Adult Vaccines Revenue in 2022
Figure 9. By Type - Global Adult Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Adult Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Adult Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Adult Vaccines Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Adult Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Adult Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Adult Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Adult Vaccines Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Adult Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Adult Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Adult Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Adult Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Adult Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Adult Vaccines Sales Market Share, 2018-2029
Figure 23. US Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Adult Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Adult Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Adult Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Adult Vaccines Sales Market Share, 2018-2029
Figure 37. China Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Adult Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Adult Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Adult Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Adult Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Adult Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Adult Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Adult Vaccines by Region, 2022 VS 2029
Figure 54. Adult Vaccines Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 成人用ワクチンのグローバル市場展望 2023年-2029年：一価ワクチン、多価ワクチン(Adult Vaccines Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 大人&小児用ワクチンの世界市場見通し2023年-2029年
  • ブルーアイ症候群ワクチンの世界市場見通し2023年-2029年
  • DTaP＆Tdapワクチンの世界市場見通し2023年-2029年
  • ポリオワクチンの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆